$WEWA
WEWARDS, INC.

2023 Q4 Form 10-Q Financial Statement

#000107997323001424 Filed on October 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $43.63K $74.55K
YoY Change -22.09% 0.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $43.63K $74.55K
YoY Change -22.08% 0.22%
Operating Profit -$43.63K -$74.55K
YoY Change -22.08% 0.22%
Interest Expense $130.9K $132.3K
YoY Change -201.15% -201.24%
% of Operating Profit
Other Income/Expense, Net -$126.1K -$126.3K
YoY Change -2.55% -3.39%
Pretax Income -$169.7K -$200.8K
YoY Change -8.45% -2.08%
Income Tax
% Of Pretax Income
Net Earnings -$169.7K -$200.8K
YoY Change -8.45% -2.08%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 107.5M shares 107.5M shares
Diluted Shares Outstanding 107.5M shares 107.5M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $780.2K $810.3K
YoY Change -23.01% -23.35%
Cash & Equivalents $780.2K $810.3K
Short-Term Investments
Other Short-Term Assets $2.480K $15.08K
YoY Change 230.67% 1539.13%
Inventory
Prepaid Expenses $2.475K $15.08K
Receivables
Other Receivables
Total Short-Term Assets $782.6K $825.4K
YoY Change -22.82% -21.99%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $782.6K $825.4K
Total Long-Term Assets $0.00 $0.00
Total Assets $782.6K $825.4K
YoY Change -26.06% -27.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.00 $4.000K
YoY Change -99.37% -23.18%
Accrued Expenses $3.258M $3.127M
YoY Change 17.31% 16.25%
Deferred Revenue
YoY Change
Short-Term Debt $10.50M $2.500M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.76M $5.631M
YoY Change 392.6% 108.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $8.000M
YoY Change -23.81%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $8.000M
YoY Change -100.0% -23.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.76M $5.631M
Total Long-Term Liabilities $0.00 $8.000M
Total Liabilities $13.76M $13.63M
YoY Change 3.5% 3.3%
SHAREHOLDERS EQUITY
Retained Earnings -$18.24M -$18.07M
YoY Change 4.23% 4.37%
Common Stock $107.5K $107.5K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.98M -$12.81M
YoY Change
Total Liabilities & Shareholders Equity $782.6K $825.4K
YoY Change -26.06% -27.97%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$169.7K -$200.8K
YoY Change -8.45% -2.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$30.14K -$79.09K
YoY Change -31.14% -5.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -30.14K -$79.09K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -30.14K -$79.09K
YoY Change -31.14% -5.04%
FREE CASH FLOW
Cash From Operating Activities -$30.14K -$79.09K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001616156
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
CY2023Q3 WEWA Increase Decrease In Rightofuse Asset
IncreaseDecreaseInRightofuseAsset
usd
CY2023Q3 WEWA Operating Lease Obligation Related Party
OperatingLeaseObligationRelatedParty
usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-08-31
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
000-55957
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
WEWARDS, INC.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1230099
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
2960 West Sahara Avenue
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89102
CY2023Q3 dei City Area Code
CityAreaCode
702
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
944-5599
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107483450 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
810313 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
889405 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15075 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
587 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
825388 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
889992 usd
CY2023Q3 us-gaap Assets
Assets
825388 usd
CY2023Q2 us-gaap Assets
Assets
889992 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
100 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3126796 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2994467 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5630796 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5494567 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
13630796 usd
CY2023Q2 us-gaap Liabilities
Liabilities
13494567 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
107483 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
107483 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5161532 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5161532 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18074423 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17873590 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-12805408 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12604575 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
825388 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
889992 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
765 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
718 usd
CY2023Q3 WEWA Rent Expense
RentExpense
45000 usd
CY2022Q3 WEWA Rent Expense
RentExpense
45000 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
28787 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
28670 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
74552 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
74388 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-74552 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-74388 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
132329 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
132329 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
6048 usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
1615 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-126281 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-130714 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-200833 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-205102 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12604575 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-200833 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-12805408 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-11843885 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-205102 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12048987 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-200833 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-205102 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
14488 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
624 usd
CY2022Q3 WEWA Increase Decrease In Rightofuse Asset
IncreaseDecreaseInRightofuseAsset
42671 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3900 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9893 usd
CY2023Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
132329 usd
CY2022Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
132329 usd
CY2022Q3 WEWA Operating Lease Obligation Related Party
OperatingLeaseObligationRelatedParty
-42671 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79092 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-83290 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-79092 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-83290 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
889405 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1140382 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
810313 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1057092 usd
CY2015Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
6000000 shares
CY2015Q2 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.738 pure
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8130000 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8130000 shares
CY2015Q2 WEWA Sale Of Stock Number Of Share Issued In Transaction
SaleOfStockNumberOfShareIssuedInTransaction
340000 shares
CY2015Q4 WEWA Number Of Common Shares Sold Through Stock Purchase Agreement
NumberOfCommonSharesSoldThroughStockPurchaseAgreement
6000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_z8GFlMAFKLij" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86A_zm1PNohylIci">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zqYJevsMWJw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86A_zaIITqo69cFe">Concentrations of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20230831_zuaNNT9L1KTg" title="FDIC insured amount">250,000</span> under current regulations. The Company had approximately $<span id="xdx_90B_eus-gaap--CashUninsuredAmount_pp0p0_c20230831_zPsdd647Qfdc" title="Excess of FDIC insured limits">560,313</span> and $<span id="xdx_90E_eus-gaap--CashUninsuredAmount_pp0p0_c20230531_z0bbfRiCPTjk" title="Excess of FDIC insured limits">640,755</span> in excess of FDIC insured limits at August 31, 2023 and May 31, 2023, respectively. The Company has not experienced any losses in such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
560313 usd
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
640755 usd
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18074423 usd
CY2023Q3 WEWA Working Capital
WorkingCapital
4805408 usd
CY2023Q3 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2023Q2 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
132329 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
132329 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9000000 usd

Files In Submission

Name View Source Status
wewa-20230831_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001079973-23-001424-index-headers.html Edgar Link pending
0001079973-23-001424-index.html Edgar Link pending
0001079973-23-001424.txt Edgar Link pending
0001079973-23-001424-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex32x1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wewa-20230831.xsd Edgar Link pending
wewa_10q.htm Edgar Link pending
wewa-20230831_def.xml Edgar Link unprocessable
wewa-20230831_pre.xml Edgar Link unprocessable
wewa-20230831_lab.xml Edgar Link unprocessable
wewa_10q_htm.xml Edgar Link completed